NCT07441629

Brief Summary

The goal of this qualitative study is to identify and better understand the symptoms of stricturing Crohn's disease in order to inform the development of more appropriate clinical evaluation scores. This study focuses on adult patients diagnosed with stricturing Crohn's disease who are followed in hospital gastroenterology departments. The main questions it aims to answer are:

  • Which symptoms are perceived by patients as the most specific and significant features of stenosing Crohn's disease?
  • Which symptoms are perceived by patients as early warning signs of a stenosing flare?
  • How does stenosing Crohn's disease impact daily life, mental health, and quality of life, and what coping strategies do patients use to manage symptoms and limit their impact? Participants will:
  • Take part in a one-hour individual semi-structured interview, conducted in person (at the hospital, at home, or in another agreed location) or by videoconference
  • Have the interview audio-recorded for transcription and qualitative analysis
  • Be offered the opportunity to review and validate the transcript and summary of their interview before final anonymized analysis

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
5mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
May 2026Nov 2026

First Submitted

Initial submission to the registry

February 16, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

May 20, 2026

Status Verified

May 1, 2026

Enrollment Period

4 months

First QC Date

February 16, 2026

Last Update Submit

May 18, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of patient-reported symptom categories associated with stenosing Crohn's disease, derived from thematic content analysis of single semi-structured interviews.

    Up to 5 months

Secondary Outcomes (5)

  • Frequency of patient-reported symptom categories described as early warning signs of a stenosing flare, derived from qualitative content analysis of individual interviews.

    Up to 5 months

  • Frequency of patient-reported daily life impact domains identified through qualitative content analysis of individual interviews.

    Up to 5 months

  • Frequency of patient-reported mental health impact domains identified through qualitative content analysis of individual interviews.

    Up to 5 months

  • Frequency of patient-reported quality-of-life impact domains identified through qualitative content analysis of single semi-structured interviews.

    Up to 5 months

  • Frequency of patient-reported coping strategy categories identified through qualitative content analysis of individual interviews.

    Up to 5 months

Interventions

One-hour semi-structured interview in person or by videoconference. Interviews will be audio-recorded, pseudonymized, transcribed, and analyzed, and participants can review their transcripts before final anonymization.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient (≥ 18 years old), with a confirmed diagnosis of Crohn's disease presenting a stricturing form of the disease

You may qualify if:

  • Adult patient (≥ 18 years old).
  • With a confirmed diagnosis of Crohn's disease.
  • Presenting a stricturing form of the disease (confirmed clinically, endoscopically, radiologically, or surgically).
  • Followed in a hospital department managing inflammatory bowel diseases (IBD).
  • Clinically stable at the time of the interview (not experiencing an acute episode requiring urgent hospitalization).
  • Able to understand and speak French, in order to participate in a qualitative interview.

You may not qualify if:

  • Current hospitalization for a severe Crohn's disease flare, acute intestinal obstruction, or any situation requiring urgent medical care.
  • Severe cognitive impairment, communication deficits, or acute psychiatric disorder preventing understanding of the interview or reliable expression of experiences.
  • Major uncontrolled medical comorbidity (e.g., active cancer under treatment, severe heart failure) making the interview inappropriate or likely to confound symptom interpretation.
  • Technical inability to participate in an interview (no access to the proposed modalities: unable to travel, no access to videoconference if a remote interview is required).
  • Pregnant women
  • Persons deprived of their liberty
  • Persons receiving psychiatric care
  • Persons admitted to a healthcare or social institution
  • Adults subject to a legal protection measure
  • Persons unable to express their consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Grenoble Alpes

La Tronche, 38700, France

Location

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

March 2, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

May 20, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) will not be shared due to the qualitative nature of the study. The data consist of interview transcripts containing health-related information and sensitive personal content. Full anonymization cannot be guaranteed, and data sharing was not covered by the informed consent or the European regulatory framework (GDPR) applicable to this study.

Locations